G00033MO

Summary
GlyTouCan ID
G00033MO
IUPAC Condensed
Gal(b1-3)[GlcNAc(b1-6)]GalNAc(a1-
Motifs
O-Glycan core 2
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
586.22
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
2452 2453 3486 3487 13751 16601 23753 30426 30851 33633 34767 35109 35110 36265 38265 38269 38650 42743 46429 47878
3D Structures
GlycoShape
G00033MO
Displaying 1 entry
Archetype α β
G00034MO
G00033MO
G24720OO
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B3GALNT2 UDP-GalNAc
G00033MO
Ser/Thr
G01707KB
Ser/Thr
GCNT1 UDP-GlcNAc
G00031MO
Ser/Thr (core 2)
G00033MO
Ser/Thr (core 2)
GCNT3 UDP-GlcNAc
G00031MO
Ser/Thr
G00033MO
Ser/Thr
GCNT4 UDP-GlcNAc
G00031MO
Ser/Thr
G00033MO
Ser/Thr
Displaying entries 1 - 5 of 22 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
ST3GAL1 CMP-Neu5Ac
G00033MO
O-glycan Synthesis
G85608AG
O-glycan Synthesis
FUT2 GDP-Fuc
G00033MO
O-glycan Synthesis
G32426JY
O-glycan Synthesis
B4GALT4 UDP-Gal
G00033MO
pNP
G64973KT
pNP
B4GALT1 UDP-Gal
G00033MO
O-glycan Synthesis
G64973KT
O-glycan Synthesis
B3GALNT2 UDP-GalNAc
G00033MO
(core2)-pNP
G01707KB
(core2)-pNP
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
GAL3ST3 PAPS
G00033MO
octyl
B3GNT7 UDP-GlcNAc
G00033MO
core 2-pNp
B3GNT8 UDP-GlcNAc
G00033MO
core 2-pNp
B3GNT6 UDP-GlcNAc
G00033MO
[alpha]-pNP(core 2)
KEGG BRITE Database
Sequence Descriptors
GlycoCT
RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
3b:b-dgal-HEX-1:5
4b:b-dglc-HEX-1:5
5s:n-acetyl
LIN
1:1d(2+1)2n
2:1o(3+1)3d
3:1o(6+1)4d
4:4d(2+1)5n
WURCS
WURCS=2.0/3,3,2/[a2112h-1a_1-5_2*NCC/3=O][a2112h-1b_1-5][a2122h-1b_1-5_2*NCC/3=O]/1-2-3/a3-b1_a6-c1
Literature
Displaying entries 1 - 10 of 42 in total
PubMed ID Title First Author Publication Date Source
35022400 Mammalian brain glycoproteins exhibit diminished glycan complexity compared to other tissues Williams SE 2022 Jan 12
  • GlyGen
34191522 The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson's Disease Wilkinson H 2021 Aug 6
  • GlyGen
33871970 Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells Gstottner C 2021 Apr 19
  • GlyGen
  • PubChem
32841605 Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor Zhao P 2020 Oct 07
  • GlyGen
  • PubChem
32310329 Comprehensive N- and O-glycosylation mapping of human coagulation factor V Ma C 2020 Aug
  • GlyGen
  • PubChem
31620994 Structural Basis of Glycan Recognition in Globally Predominant Human P[8] Rotavirus Sun X 2019 Oct 09
  • PubChem
31118252 GII.13/21 noroviruses recognize glycans with a terminal beta-galactose via an unconventional glycan binding site Cong X 2019 May 22
  • PubChem
29720519 Glycan Binding Specificity and Mechanism of Human and Porcine P[6]/P[19] Rotavirus VP8*s Sun X 2018 Jul 15
  • PubChem
25187573 The O-glycomap of Lubricin, a Novel Mucin Responsible for Joint Lubrication, Identified by Site-specific Glycopeptide Analysis Ali L 2014 Dec
  • GlyGen
  • PubChem
21402433 Synthesis of the carbohydrate moiety from the parasite Echinococcus multilocularis and their antigenicity against human sera Koizumi A 2011 May
  • PubChem
PubAnnotation
Displaying entries 1 - 5 of 10 in total
Title Authors Source Publication Date PubMed ID
Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
  • Müller S
  • Hanisch FG
J Biol Chem 2002 Jul 19 12000758
Specificities of N-acetylglucosamine-6-O-sulfotransferases in relation to L-selectin ligand synthesis and tumor-associated enzyme expression.
  • Uchimura K
  • El-Fasakhany FM
  • Hori M
  • Hemmerich S
  • Blink SE
  • Kansas GS
  • Kanamori A
  • Kumamoto K
  • Kannagi R
  • Muramatsu T
J Biol Chem 2002 Feb 8 11726653
The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
  • Dalziel M
  • Whitehouse C
  • McFarlane I
  • Brockhausen I
  • Gschmeissner S
  • Schwientek T
  • Clausen H
  • Burchell JM
  • Taylor-Papadimitriou J
J Biol Chem 2001 Apr 6 11118434
MUC1 and cancer.
  • Taylor-Papadimitriou J
  • Burchell J
  • Miles DW
  • Dalziel M
Biochim Biophys Acta 1999 Oct 8 10571020
An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
  • Burchell J
  • Poulsom R
  • Hanby A
  • Whitehouse C
  • Cooper L
  • Clausen H
  • Miles D
  • Taylor-Papadimitriou J
Glycobiology 1999 Dec 10561455

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025